In our study, we performed focused CRISPR screens targeting 193 known and predicted GPI-APs and identified LY6E as the key downstream effector of the GPI biosynthesis pathway we found in our larger genome-wide screen in restricting the infection of multiple coronaviruses. The gene discussed is LY6E; the disease is infection.